Summary
The radioactive constituents of specimens of serum, urine and faeces of wistar rats, beagle dogs and rhesus monkeys following peroral and intravenous administration of praziquantel-14C were analyzed by radio thin layer chromatographic techniques. Corresponding investigations were done with specimens of bile and liver tissue of wistar rat. These investigations yielded the following results:
Praziquantel is quantitatively and rapidly absorbed and metabolized by all species. No unmetabolized drug was found in any of the excretion products. The excretion occurs as a variety of metabolites, some of them representing conjugates with glucuronic and/or sulfuric acid.
The serum metabolite patterns of praziquantel following p. o. administration are characterized by a strong “first pass effect: after p. o. administration only a small proportion of unchanged drug reaches the general blood circulation. In contrast to this substantial amounts of praziquantel are present in the serum over a longer time period after i. v. administration.
These differences are due to intensive metabolisation by the liver, being particularly prominent in wistar rats and rhesus monkeys, and somewhat less in beagle dogs.
Similar content being viewed by others
References
Faro, H. P., (1976), Internal Report, E. Merck.
Steiner, K., Diekmann, H. W., Garbe, A. and Nowak, H., (1976), Pharmacokinetics of praziquantel-14C in animals, to be published in this journal.
Mürmann, P., Eberstein, M. V. and Frohberg, H., (1976), Zur Verträglichkeit von Droncit®, to be published in Vet. Med. Nachr.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Diekmann, H.W., Buhring, K.U. The fate of praziquantel in the organism III. Metabolism in rat, beagle dog and rhesus monkey. European Journal of Drug Metabolism and Pharmacokinetics 1, 107–112 (1976). https://doi.org/10.1007/BF03189264
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189264